Establishment Labs Holdings Inc. (ESTA) Financial Statements
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
In fiscal 2025, Establishment Labs reported revenue of $211.1M, up 27.1% from $166.0M the year before. Net income was -$51.1M (a -24.2% net margin), or -$1.72 per diluted share. Gross margin was 69.3% and operating margin was -18.5%. Operating activities generated -$50.9M of cash, leaving -$56.9M of free cash flow. At fiscal year end, Establishment Labs held $357.2M in total assets against $333.6M in total liabilities, including $75.6M of cash and equivalents.
Open the full interactive Establishment Labs financials → Quarterly statements, key ratios, valuation history and price charts.
Establishment Labs Key Stats
| Share Price | $58.45 |
|---|---|
| Market Cap | $1.76B |
| Revenue YoY Growth | +27.1% |
| 52-Week Range | $41.16 – $95.65 |
| Shares Outstanding | 30.1 million (basic, 2026 Q2) |
Establishment Labs Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $84.7M | $126.7M | $161.7M | $165.2M | $166.0M | $211.1M |
| Gross Profit | $52.5M | $85.4M | $106.6M | $107.0M | $109.5M | $146.3M |
| Operating Income | -$27.9M | -$25.1M | -$39.7M | -$65.0M | -$50.0M | -$39.0M |
| Pre-Tax Income | -$38.0M | -$39.7M | -$72.8M | -$78.6M | -$84.6M | -$58.0M |
| Income Tax | $104,000 | $1.4M | $2.4M | -$81,000 | -$32,000 | -$7.0M |
| Net Income | -$38.1M | -$41.1M | -$75.2M | -$78.5M | -$84.6M | -$51.1M |
| Diluted EPS | -$1.63 | -$1.72 | -$3.08 | -$3.07 | -$3.00 | -$1.72 |
Establishment Labs Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $53.8M | $64.6M | $59.9M | $67.5M |
| Net Income | -$11.1M | -$2.6M | -$13.4M | -$11.7M |
| Diluted EPS | -$0.38 | -$0.09 | -$0.45 | -$0.39 |
Establishment Labs Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | — | — | — | $40.0M | $90.3M | $75.6M |
| Current Assets | $132.3M | $113.3M | $149.9M | $174.9M | $243.0M | $249.9M |
| Total Assets | $156.4M | $139.5M | $211.1M | $268.6M | $346.8M | $357.2M |
| Current Liabilities | $25.9M | $31.9M | $39.0M | $57.1M | $68.3M | $82.1M |
| Total Long-Term Debt | $49.8M | $51.9M | — | $188.7M | $219.6M | $247.5M |
| Total Liabilities | $81.4M | $88.8M | $219.2M | $250.2M | $293.7M | $333.6M |
| Shareholders' Equity | $75.0M | $50.7M | -$8.2M | $18.4M | $53.1M | $23.5M |
Establishment Labs Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$12.5M | -$27.5M | -$52.2M | -$88.5M | -$58.5M | -$50.9M |
| Cash From Investing | -$5.6M | -$7.2M | -$34.8M | -$24.5M | -$15.6M | -$7.0M |
| Cash From Financing | $64.7M | $4.1M | $100.3M | $86.2M | $125.9M | $40.4M |
| Free Cash Flow | -$14.9M | -$30.0M | -$55.0M | -$96.4M | -$64.6M | -$56.9M |
Figures from Establishment Labs' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Establishment Labs financials page for every line item.
Establishment Labs Company Profile
| Ticker | ESTA |
|---|---|
| Exchange | Nasdaq |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Headquarters | Alajuela, Costa Rica |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001688757 |
Frequently Asked Questions
What was Establishment Labs' revenue in fiscal 2025?
Establishment Labs (ESTA) reported revenue of $211.1M for fiscal 2025.
What is Establishment Labs' annual revenue history?
Establishment Labs' annual revenue by fiscal year: 2020: $84.7M; 2021: $126.7M; 2022: $161.7M; 2023: $165.2M; 2024: $166.0M; 2025: $211.1M.
What was Establishment Labs' net income in fiscal 2025?
Establishment Labs reported net income of -$51.1M for fiscal 2025.
What was Establishment Labs' earnings per share (EPS) in fiscal 2025?
Establishment Labs' diluted EPS was -$1.72 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Establishment Labs generate in fiscal 2025?
Establishment Labs generated -$56.9M of free cash flow in fiscal 2025.
What was Establishment Labs' revenue last quarter?
In its most recent reported quarter (2026 Q2), Establishment Labs reported revenue of $67.5M.
How much debt does Establishment Labs have?
Establishment Labs reported $247.5M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Establishment Labs are outstanding?
Establishment Labs reported a weighted average of 30.1 million basic shares outstanding in 2026 Q2.
What is Establishment Labs' market cap?
Based on its latest closing price, Establishment Labs (ESTA) has a market capitalization of about $1.76B.
When does Establishment Labs' fiscal year end?
Establishment Labs' fiscal year end, as registered with the SEC, is December 31.
Where is Establishment Labs headquartered?
Establishment Labs lists its business address in Alajuela, Costa Rica in its SEC filings.
Establishment Labs Competitors & Similar Companies
See all 20 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies →